IMO wait for quarterly to see what costs are like...
Yes with the 2500 tinctures arriving now margins will improve for sure.
Estimated outgoings for this quarter as per last quarter guidance was 1.1M but most of that was for R&D.
All pot stocks on ASX so far have horrible costs.... If IHL shows low costs as well it will be insane and put us as the clear sustainable leader IMO.
Ann: Record Sales for June Quarter, page-66
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)